Yale experts see rise in younger, turbo cancer

Yale experts see rise in younger, turbo cancer

A sudden rise in younger people with early onset cancers which are more aggressive with more (and unusual) genetic change has been increasingly noted - colorectal, breast and GI tract cancers seem to lead the way.

 

Dr. Harvey Risch first reported in September 2023 that Clinicians at Yale Medical School were seeing some new cancer situations in adults as young as 25, with no family history of developing colorectal cancer, suddenly developing highly aggressive forms of the disease. So aggressive that between diagnosis  and first treatment, the cancers have grown dramatically (1).  This phenomenon has rapidly accelerated since the Pandemic.

 

These ‘turbo cancers’ do not conform to the normal behaviour of cancers, not only are they more aggressive, but there seem to be more genetic issues in these cancers.

 

Risch is Professor Emeritus of Epidemiology in the Department of Epidemiology and Public Health at the Yale School of Public Health and Yale School of Medicine.

 

In 2022 there was a report in Nature (2) from researchers at Harvard, amongst others referring to increases in young cancer, often described as Early Onset Cancer. Yale Researchers believe early onset cancer has gone turbo since the pandemic. 

 

The CEO of the American Cancer Society described the report as “a call to arms.”

 

Doctor Jeremy Kortmansky and Doctor Mariya Rozenblit of Yale Medicine have observed that younger adults tend to have more aggressive-appearing cancers compared to older adults. And, so far, this difference is seen in various cancer types, including colorectal, gastric and oesophageal cancers and breast cancer. In fact, Yale Cancer Center has now developed an Early Onset Cancer Program’ to focus on patients with these aggressive cancers and diagnosed between the ages of 18-49. They have done this in partnership with the Smilow Cancer Hospital, a leading comprehensive cancer center in Connecticut, affiliated with the Yale Cancer Center.

 

Dr Veda Giri is the newly appointed director in charge of Yale Cancer Center and Smillow’s Early Onset Program. When Dr. Giri surveyed Smilow’s patient records from the last two years, she discovered approximately 1,300 cases of early onset breast cancer, about 600 cases of early onset gastrointestinal cancers, and close to another thousand cases across other cancer types. These new figures came as a shock. “It’s a real issue that has to be prioritized,” Giri stated.

 

But it’s not just the aggression of these cancers; the genetic issues mean that drugs may not currently exist to treat these cancers. Then younger patients may also have young families, may have more financial issues and may worry more about fertility.

 

Alberta Bourla the CEO of Pfizer talked extensively about Turbo cancer in his 2023 ‘Oxford Interview’’ he said then that a third of all cancers will be turbo cancers. “We too are seeing this phenomenon at CANCERactive. In the last 10 days we have had four NHS nurses all under 35 years old;  two with highly aggressive colorectal cancer, two with breast cancer and multiple mets. Each had been forced to have four or five Covid vaccines of which two or three were mRNA boosters. It’s hard to believe the mRNA vaccines have nothing to do with Turbo cancer. And a similar concern has been expressed by UK oncologist and virologist, Professor Angus Dalgleish (3). Other cancers on the increase beyond usual numbers are lymphoma, primary and, especially secondary, brain cancer and lung cancer. The vaccines need to be pulled off the market until there is proper Phase III research on the mRNA carrier, not just the spike protein ”. 

 

Go to: Turbo cancer - is this the new pandemic?

 

******

References

 

  1. The rise of turbo cancer in young people; https://www.theepochtimes.com/epochtv/dr-harvey-risch-rise-in-aggressive-turbo-cancers-and-especially-among-younger-people-atlnow-5489582 

  2.  Is early-onset cancer an emerging global epidemic? Current evidence and future implications;  Ugai, T., Sasamoto, N., Lee, HY. et al.  Nat Rev Clin Oncol 19, 656–673 (2022). https://doi.org/10.1038/s41571-022-00672-8

  3. Professor sees vaccines causing cancer - https://www.canceractive.com/article/top-professor%20sees%20vaccines%20causing%20cancer  

 

 


   .

  Approved by the Medical Board.  Click Here

 


 

2024 Research
CancerAcitve Logo
Subscribe (Free e-Newsletter)

Join Chris'
Newsletter

Join Chris' NewsletterSignup today for free and be the first to get notified on new updates.